Corporate information

Registration country

Company type

The corporate venture fund of the healthcare company Roche

Relation

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 15 of 15
Profile Country Date Funding
Alnylam Pharmaceuticals Inc N/A
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. Series D
Conatus Pharmaceuticals Inc Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. N/A
CytomX Therapeutics Developer of proteolytically-activated antibodies Series B
Halozyme Therapeutics Inc (Halozyme Inc) Biopharmaceutical company developing & commercializing products targeting the extracellular matrix. N/A
Inimex Pharmaceuticals Inc Series B
Intradigm Corp N/A
IRX Therapeutics Inc N/A
Nereus Pharmaceuticals Inc Series E
Nereus Pharmaceuticals Inc Series D
Addex Pharmaceuticals SA Switzerland-based drug company focused on CNS disorders N/A
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform N/A
Horizon Discovery Ltd Series C
Horizon Discovery Ltd Series C
Opsona Therapeutics Ltd Innate immune drug development company Series C

Current team

Past employees

Selected Products / Customers

Financials